Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 15Completed 11Active not recruiting 9Withdrawn 5Terminated 5Unknown 3Suspended 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Head & Neck 3Breast 3Tumor-Agnostic 2Genitourinary 2Gastrointestinal 2CNS 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Dermatologic 1

Conditions

Neoplasms 1Neoplasm Metastasis 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2E 7107 2Biopsy 2trastuzumab deruxtecan 1neratinib 1ipatasertib 1eniluracil 1Topotecan 1Taxes 1Surveys and Questionnaires 1Standard of Care 1Radiofrequency Ablation 1Practice Guidelines as Topic 1Paclitaxel 1Maltose 1Magnetic Resonance Imaging 1Fluorodeoxyglucose F18 1Flucytosine 1Drug Implants 1Cyclophosphamide 1Cell Count 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Magnetic Resonance Spectroscopy × Tumor-Agnostic × Clear all
NCT05554380 2026-05-22

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

National Cancer Institute (NCI)

Phase 2 Suspended
33 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05887882 2026-04-24

PNOC028

University of California, San Francisco

Phase 1 Suspended
24 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡